Edgewise Therapeutics, Inc.
$42.76
-1.43 (-3.24%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +4.0%
- 3 Months
- +25.2%
- YTD
- +72.3%
- 1 Year
- +195.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 78.0%
- Largest decline max drawdown, since Aug 2025
- -21.0%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.77
Own EWTX?
See how EWTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.